CrushSCI.com
Journal Selection & Manuscript Polishing Services
Pharmacology Research & Perspectives journal cover Medicine
Back to journal directory

Review Cycle Records

Pharmacology Research & Perspectives

Wiley SCIE OA
2026 Emerging Zone 32025 CAS Zone 42025 JCR Q3
193.9Average days
170Median days
41Fastest days
491Longest days
1612025 publications

Paper Review Records

All Paper Review Records

18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

171 days

Hirudin Attenuates Uric Acid‐Induced Renal Tubular Injury via TNFRSF6B ‐Mediated Suppression of NF ‐ κB Signaling

AuthorsYingxue Zhao; Yongjie Qin; Lanzhi He; Haikun Luo; Ying Mo; Weihai Zhou; Huamei He; Ganping Zhou; Xihua Liu

Affiliations1. Department of Pharmacy Jiangbin Hospital of Guangxi Zhuang Autonomous Region Nanning China; 2. Guangxi Keyken Technology Group Co., Ltd. Nanning China; 3. GuangXi Health Science College Nanning China

Source PDF DOI Publisher page
208 days

3D Liver Fibrosis Models in Lab: A Novel Modality for Drug Screening

AuthorsHani Keshavarz Alikhani; Fatemeh Majidi; Mahsa Ghasemzad; Anastasia Shpichka; Anastasia Nestorova; Zahra Hendi; Elham Rismani; Daria Kuznetsova; Peter Timashev; Massoud Vosough; Abbas Piryaei

Affiliations1. Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology Academic Center for Education, Culture and Research Tehran Iran; 2. Institute for Regenerative Medicine Sechenov University Moscow Russia; 3. Molecular Medicine Department, Biotechnology Research Center (BRC) Pasteur Institute of Iran Tehran Iran; 4. World‐Class Research Center “Digital Biodesign and Personalized Healthcare” Sechenov University Moscow Russia; 5. Experimental Cancer Medicine, Institution for Laboratory Medicine Karolinska Institute Stockholm Sweden; 6. Department of Medical Biotechnology, School of Advanced Technologies in Medicine Tehran University of Medical Sciences Tehran Iran; 7. Department of Biology and Anatomical Sciences, School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran; 8. Urogenital Stem Cell Research Center Shahid Beheshti University of Medical Sciences Tehran Iran

Source PDF DOI Publisher page
251 days

Chronotherapy in Hematological Malignancies: Evaluating the Rationale and Evidence

AuthorsAndrej Belančić; Marko Skelin; Yun Wah Lam; Almir Fajkić; Bruna Perkov‐Stipičin; Rossana Roncato; Ivan Krečak; Marko Lucijanić

Affiliations1. Department of Basic and Clinical Pharmacology and Toxicology University of Rijeka, Faculty of Medicine Rijeka Croatia; 2. General Hospital Šibenik Šibenik Croatia; 3. Department of Diagnostic Sciences, School of Nursing and Health Sciences Hong Kong Metropolitan University Hong Kong SAR China; 4. Department of Pathophysiology University of Sarajevo Sarajevo Bosnia and Herzegovina; 5. Department of Medicine University of Udine Udine Italy; 6. Faculty of Medicine University of Rijeka Rijeka Croatia; 7. University of Applied Sciences, Šibenik Croatia; 8. Division of Haematology, Department of Internal Medicine Clinical Hospital Dubrava Zagreb Croatia; 9. Department of Scientific Research and Translational Medicine Clinical Hospital Dubrava Zagreb Croatia; 10. Department of Internal Medicine School of Medicine University of Zagreb Zagreb Croatia

Source PDF DOI Publisher page
343 days

Reported Characteristics of Anaphylaxis Associated With Glatiramer Acetate: A Pharmacovigilance Analysis of the FDA and Canadian Databases

AuthorsTailei Nie; Hongyu Liu; Chuanxu Cheng; Jian Li; Jiajing Lu

Affiliations1. Department of Pharmacy, Affiliated Hospital of Yangzhou University Yangzhou University Yangzhou Jiangsu China; 2. Department of Biomedical Engineering Columbia University New York New York USA; 3. School of Biomedical Sciences and Engineering South China University of Technology Guangzhou Guangdong China; 4. Department of Pharmaceutics, School of Pharmacy China Pharmaceutical University Nanjing China

Source PDF DOI Publisher page
465 days

The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma

AuthorsFarideh A. Javid; Marin Golčić; Anja Harej Hrkać; Andrej Belančić

Affiliations1. Department of Pharmacy, School of Applied Sciences University of Huddersfield Huddersfield UK; 2. Clinic for Tumors Clinical Hospital Centre Rijeka Rijeka Croatia; 3. Department of Basic and Clinical Pharmacology With Toxicology Faculty of Medicine, University of Rijeka Rijeka Croatia

Source PDF DOI Publisher page
491 days

Targeting CD148 for Antithrombotic Therapy: Functional and Molecular Evaluation of AKB ‐9778

AuthorsLina El Badaoui; Stipo Jurcevic; Yotis A. Senis; Alastair J. Barr

Affiliations1. School of Life Sciences University of Westminster London UK; 2. Centre for Cardiovascular and Nutrition Research, INSERM 1263, INRAE 1260, Faculty of Medicine Aix‐Marseille University Marseille France

Source PDF DOI Publisher page
41 days

Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development

AuthorsAndreas Halman; Ross Corriden

Affiliations1. Peter MacCallum Cancer Centre Melbourne Victoria Australia; 2. Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne Victoria Australia; 3. Cancer Therapies, Stem Cell Medicine Murdoch Children's Research Institute Parkville Victoria Australia; 4. Pharmacology Research & Perspectives Editorial Board New Castle New South Wales Australia

Source PDF DOI Publisher page
124 days

Berberine and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Hope or Hype?

AuthorsRuth Nona; Eric Kalo

Affiliations1. College of Medicine and Dentistry James Cook University Smithfield Queensland Australia

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.